Vancouver, British Columbia–(Newsfile Corp. – April 3, 2020) – EGF Theramed Health Corp. (CSE: TMED) announces that Mr. Sydney Au has resigned as a director of EGF Theramed Health Corp. and that Mr. Chris Brown has resigned as President of the company and of its subsidiary Western Agri Supply Solutions Corp. Following the resignations, the Company will be doing a full audit of company financials.The company wishes to thank Mr. Au as a founding director and his many years of service for his contributions to the company and wishes him well in his future endeavors.
For further information, please contact:
Jatinder Dhaliwal
604-368-3551
DISCLAIMERS
This news release contains forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators and on the OTC Markets website which is posted on www.sedar.com, https://thecse.com/en/listings/technology/egf-theramed-health-corp, and http://www.otcmarkets.com/stock/EVAHF/filings. This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), or any other regulatory authority accepts responsibility for the adequacy or accuracy of this release. The Company does not undertake to update this news release unless required by applicable law.
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities law and may not be offered or sold in the “United States”, as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/54129